CBD Companies Should Continue to See Growth, Despite FDA Crackdowns

Despite the FDA recently cracking down on companies selling CBD products as dietary supplements investing experts are predicting continued growth in the niche market of the overall cannabis industry.

Want to Read the Full Article?

Posted by Jason Sanders

Jason is a versatile writer and marketer with fifteen combined years of experience. He couples this expertise with a passion for cannabis businesses and the science of medical marijuana.

CBD Companies Should Continue to See Growth, Despite FDA Crackdowns

Want to Read the Full Article?

Article Topics